Evidence map›Paper›PMID 33655378›Full record

ArticleDiabetologia2021

Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.

Nima Purvis, Sweta Kumari, Dhananjie Chandrasekera, Jayanthi Bellae Papannarao, Sophie Gandhi, Isabelle van Hout, Sean Coffey, Richard Bunton, Ramanen Sugunesegran, Dominic Parry and 4 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Nima PurvisDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Sweta KumariDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Dhananjie ChandrasekeraDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Jayanthi Bellae PapannaraoDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Sophie GandhiDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Isabelle van HoutDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Sean CoffeyDepartment of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Richard BuntonDepartment of Cardiothoracic Surgery, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Ramanen SugunesegranDepartment of Cardiothoracic Surgery, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Dominic ParryDepartment of Cardiothoracic Surgery, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Philip DavisDepartment of Cardiothoracic Surgery, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Michael J A WilliamsDepartment of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Andrew BahnDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. andrew.bahn@otago.ac.nz.
Rajesh KatareDepartment of Physiology-HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. rajesh.katare@otago.ac.nz.ORCID http://orcid.org/0000-0001-5419-7935
University of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisDiabetes mellitus causes a progressive loss of functional efficacy in stem cells, including cardiac progenitor cells (CPCs). The underlying molecular mechanism is still not known. MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate genes at the post-transcriptional level. We aimed to determine if diabetes mellitus induces dysregulation of miRNAs in CPCs and to test if in vitro therapeutic modulation of miRNAs would improve the functions of diabetic CPCs.

methodsCPCs were isolated from a mouse model of type 2 diabetes (db/db), non-diabetic mice and human right atrial appendage heart tissue. Total RNA isolated from mouse CPCs was miRNA profiled using Nanostring analysis. Bioinformatic analysis was employed to predict the functional effects of altered miRNAs. MS analysis was applied to determine the targets, which were confirmed by western blot analysis. Finally, to assess the beneficial effects of therapeutic modulation of miRNAs in vitro and in vivo, prosurvival miR-30c-5p was overexpressed in mouse and human diabetic CPCs, and the functional consequences were determined by measuring the level of apoptotic cell death, cardiac function and mitochondrial membrane potential (MMP).

resultsAmong 599 miRNAs analysed in mouse CPCs via Nanostring analysis, 16 miRNAs showed significant dysregulation in the diabetic CPCs. Using bioinformatics tools and quantitative real-time PCR (qPCR) validation, four altered miRNAs (miR-30c-5p, miR-329-3p, miR-376c-3p and miR-495-3p) were identified to play an important role in cell proliferation and survival. Diabetes mellitus significantly downregulated miR-30c-5p, while it upregulated miR-329-3p, miR-376c-3p and miR-495-3p. MS analysis revealed proapoptotic voltage-dependent anion-selective channel 1 (VDAC1) as a direct target for miR-30c-5p, and cell cycle regulator, cyclin-dependent protein kinase 6 (CDK6), as the direct target for miR-329-3p, miR-376c-3p and miR-495-3p. Western blot analyses showed a marked increase in VDAC1 expression, while CDK6 expression was downregulated in diabetic CPCs. Finally, in vitro and in vivo overexpression of miR-30c-5p markedly reduced the apoptotic cell death and preserved MMP in diabetic CPCs via inhibition of VDAC1. CONCLUSIONS/

interpretationOur results demonstrate that diabetes mellitus induces a marked dysregulation of miRNAs associated with stem cell survival, proliferation and differentiation, and that therapeutic overexpression of prosurvival miR-30c-5p reduced diabetes-induced cell death and loss of MMP in CPCs via the newly identified target for miR-30c-5p, VDAC1.

Indexed as

Gene Expression RegulationAnimalsCell ProliferationCell SurvivalDiabetes Mellitus, Type 2Heart AtriaHumansMiceMicroRNAsStem CellsMicroRNAsCardiac progenitor cellsDiabetes mellitusmicroRNAmiR-30c-5pMitochondrial membrane potentialStem cell therapy

Identifiers

PMID33655378
OpenAlexW3134448710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.